Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. 4 Shares withheld for taxes Chief Commercial Officer gave up 4,389 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Executive Officer gave up 13,781 shares (to pay taxes)
  3. 4 Open-market buy Director bought 6,000 shares at an average $3.38 ($20,250)
  4. 4 Grant or award Chief Legal Officer acquired 50,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Chief Commercial Officer bought 1,000 shares at $4.00 ($4,000)
  7. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  8. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.71 ($37,100)
  9. 4 Open-market buy Director bought 6,000 shares at $4.54 ($27,258)
  10. 4/A Open-market buy Director bought 10,000 shares at $4.65 ($46,500)
  11. 4/A Open-market buy Director bought 3,000 shares at $4.33 ($12,980)
  12. 4/A Open-market buy Director bought 10,000 shares at $4.37 ($43,735)
  13. 4/A Open-market buy Chief Executive Officer bought 5,000 shares at $4.58 ($22,900)
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. 4 Grant or award Director acquired 3,000 shares (grant or award)
  16. 4 Grant or award Director acquired 10,000 shares (grant or award)
  17. 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 37,443 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 5 of 26 · 513 filings